Formulation of nasal analgesic sprays with diclofenac sodium, ibuprofen, paracetamol, and evaluation of in vitro toxicity
Science Progress · 2024
DOI: 10.1177/00368504241304200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Progress, 2024. Verfasst von Vildan Betul Yenigun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Diclofenac, Ibuprofen, Acetaminophen, Nasal Sprays. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bezmialem Vakıf Üniversitesi.
Abstract (Originalsprache)
Objective
Intranasal analgesic sprays represent a safe, efficacious method for pain relief, with a shorter working time compared to oral painkillers. This study aimed to develop nasal sprays using commonly available over-the-counter analgesics, providing an alternative treatment option that is more convenient and potentially more effective in managing pain, particularly in pediatric patients.
Methods
Three different nasal spray formulations with the contents of diclofenac sodium, ibuprofen, and paracetamol were created, and characterization studies were completed. The possible cytotoxic, genotoxic, and apoptotic effects of nasal sprays were studied on human normal skin fibroblastic cells (CCD-1079Sk) using WST cell viability test, alkaline single-cell gel electrophoresis analysis, and acridine orange/ethidium bromide staining, respectively.
Results
The formulations’ physical appearance and drug content were assessed, yielding nonsignificant results ( p > 0.05). All formulations were determined at pH 5.5–6.2 so that the pH values of the prepared formulations were compatible with the pH value of the nasal mucosa. Selected nasal spray formulations were stable for 90 days, and the safe doses were chosen as 0.0625, 0.375, and 1.25 mg/mL for diclofenac, ibuprofen, and paracetamol, respectively, by not showing toxicity even at 24 h.
Conclusion
This study demonstrated that nasal sprays containing paracetamol, ibuprofen, and diclofenac sodium can be successfully formulated. These new formulations may provide alternative treatment and easier application for patients unable to swallow or refuse to take oral analgesics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
- Vocational School of Health Sciences, Bezmialem Vakif University, Istanbul, Turkey.
- Department of Otorhinolaryngology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University-Cerrahpasa, Istanbul, Turkey.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, Turkey.
ORCID-Profile: Vildan Betul Yenigun, Abdurrahim Kocyigit
Förderung
- Bezmialem Vakıf Üniversitesi
Zitieren
APA
Yenigun, V. B., Yenigun, A., Sagiroglu, A. A., Kocyigit, A., & Ozturan, O. (2024). Formulation of nasal analgesic sprays with diclofenac sodium, ibuprofen, paracetamol, and evaluation of in vitro toxicity. Science Progress. https://doi.org/10.1177/00368504241304200
Vancouver
Yenigun VB, Yenigun A, Sagiroglu AA, Kocyigit A, Ozturan O. Formulation of nasal analgesic sprays with diclofenac sodium, ibuprofen, paracetamol, and evaluation of in vitro toxicity. Science Progress. 2024. doi:10.1177/00368504241304200
BibTeX
@article{Yenigun2024,
author = {Yenigun, Vildan Betul and Yenigun, Alper and Sagiroglu, Ali Asram and Kocyigit, Abdurrahim and Ozturan, Orhan},
title = {Formulation of nasal analgesic sprays with diclofenac sodium, ibuprofen, paracetamol, and evaluation of in vitro toxicity},
journal = {Science Progress},
year = {2024},
doi = {10.1177/00368504241304200}
}
EUVIMED